EGFR and lung cancer: Additionally, by using cBioPortal for Cancer Genomics database, we have found a reduction in median months of survival in lung cancer patients that exhibit an upregulation of a nuclear EGFR gene signature, thus showing a trend between nuclear EGFR and poor prognosis in NSCLC (Figure 7).